Belite Bio, Inc
BLTEAs of the close on Sep 25, 2026
Price
$167.33
Market cap
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
P/E (diluted TTM)
—
The last four quarters are not all on file
EPS (TTM)
—
The last four quarters are not all on file
Dividend yield
—
Figures are per ordinary share in the filer's currency; the US price is per depositary share
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Belite Bio, Inc Makes Money
No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 6 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 22, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 2026-03-31 | 570,088 | Not shown | SEC filing |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 2026-03-31 | 19,600 | Not shown | SEC filing |
| MPM BIOIMPACT LLC | 2026-03-31 | 88,045 | Not shown | SEC filing |
| PFM Health Sciences, LP | 2026-03-31 | 59,432 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2026-03-31 | 105,509 | Not shown | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 3 | Not shown | SEC filing |
| JANE STREET GROUP, LLC | 2026-03-31 | 12,222 | Not shown | SEC filing |
| Rossby Financial, LCC | 2026-03-31 | 55 | Not shown | SEC filing |
| Blackstone Inc. | 2026-03-31 | 10,692 | Not shown | SEC filing |
| TUDOR INVESTMENT CORP ET AL | 2026-03-31 | 1,596 | Not shown | SEC filing |
| Virtus Investment Advisers, LLC | 2026-03-31 | 1,929 | Not shown | SEC filing |
| Merit Financial Group, LLC | 2026-03-31 | 1,415 | Not shown | SEC filing |
| WELLS FARGO & COMPANY/MN | 2026-03-31 | 124 | Not shown | SEC filing |
| JONES FINANCIAL COMPANIES LLLP | 2026-03-31 | 6 | Not shown | SEC filing |
| Amundi | 2026-03-31 | 4,210 | Not shown | SEC filing |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2026-03-31 | 281,805 | Not shown | SEC filing |
| SBI Securities Co., Ltd. | 2026-03-31 | 22 | Not shown | SEC filing |
| PERCEPTIVE ADVISORS LLC | 2026-03-31 | 151,979 | Not shown | SEC filing |
| FRED ALGER MANAGEMENT, LLC | 2026-03-31 | 62,574 | Not shown | SEC filing |
| FARALLON CAPITAL MANAGEMENT LLC | 2026-03-31 | 1,300 | Not shown | SEC filing |
- Each value is checked against Belite Bio, Inc's share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- Holocene Advisors, LP: 84,067 shares reported 2025-12-31; 494,495 shares reported 2026-03-31.
- GAMMA Investing LLC: 1,779 shares reported 2025-12-31; 1,707 shares reported 2026-03-31.
- MORGAN STANLEY: 28,013 shares reported 2025-12-31; 201,409 shares reported 2026-03-31.
- SmartHarvest Portfolios, LLC: 4,184 shares reported 2025-12-31; 4,187 shares reported 2026-03-31.
- UBS Group AG: 128,752 shares reported 2025-12-31; 768,359 shares reported 2026-03-31.
- Mirae Asset Global Investments Co., Ltd.: 645 shares reported 2025-12-31; 657 shares reported 2026-03-31.
- EverSource Wealth Advisors, LLC: 1,598 shares reported 2025-12-31; 1,608 shares reported 2026-03-31.
- GEODE CAPITAL MANAGEMENT, LLC: 10,445 shares reported 2025-12-31; 10,427 shares reported 2026-03-31.
- Caitong International Asset Management Co., Ltd: 549 shares reported 2025-12-31; 349 shares reported 2026-03-31.
- AMERIPRISE FINANCIAL INC: 13,221 shares reported 2025-12-31; 2,767 shares reported 2026-03-31.
- TD Waterhouse Canada Inc.: 70 shares reported 2025-12-31; 70 shares reported 2026-03-31.
- DEERFIELD MANAGEMENT COMPANY, L.P.: 233,813 shares reported 2025-12-31; 304,013 shares reported 2026-03-31.
Showing the 12 most recent filer reports.
56 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Belite Bio, Inc's recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-06-18 · Scholl Hendrik Peter: Larger than 112 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-06-18 · Scholl Hendrik Peter: Larger than all 123 other insider sales of American depositary share on file. SEC filing
- 2026-06-18 · Scholl Hendrik Peter: Larger than 122 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-06-16 · Scholl Hendrik Peter: Larger than 120 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-06-16 · Scholl Hendrik Peter: Larger than 117 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-06-16 · Scholl Hendrik Peter: Larger than 111 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-06-16 · Scholl Hendrik Peter: Larger than 113 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-04-09 · Lin Yu-Hsin: Larger than 118 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-04-09 · Chuang Hao-Yuan: Larger than 114 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-04-09 · Lin Yu-Hsin: Larger than 121 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-04-09 · Chuang Hao-Yuan: Larger than 115 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-04-09 · Chuang Hao-Yuan: Larger than 115 of the 123 other insider sales of American depositary share on file. SEC filing
- 2026-04-09 · Lin Yu-Hsin: Larger than 119 of the 123 other insider sales of American depositary share on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-18 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −3,748 | 144.66 | SEC filing |
| 2026-06-18 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −96 | 147.11 | SEC filing |
| 2026-06-18 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −4,861 | 145.43 | SEC filing |
| 2026-06-18 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −96 | 143.90 | SEC filing |
| 2026-06-18 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −1,199 | 146.24 | SEC filing |
| 2026-06-16 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −784 | 138.18 | SEC filing |
| 2026-06-16 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −1,897 | 143.55 | SEC filing |
| 2026-06-16 | Scholl Hendrik Peter · Chief Medical Officer | American depositary share | S — Open market or private sale | −540 | 140.58 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-31 | MATA NATHAN L. · Chief Scientific Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +144,868 | SEC filing |
| 2026-03-31 | Chuang Hao-Yuan · Chief Financial Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +144,868 | SEC filing |
| 2026-03-31 | Lin Yu-Hsin · Chief Executive Officer | Stock Option (right to buy) | A — Grant, award, or other acquisition | +206,954 | SEC filing |
| 2026-03-31 | Chen Wan-Shan · Director | Stock Option (right to buy) | A — Grant, award, or other acquisition | +13,796 | SEC filing |
Showing 4 of 4 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-04-21 | Lin Yu-Hsin · Chief Executive Officer | Ordinary Share | J — Other acquisition or disposition | +10,000 | SEC filing |
| 2026-04-21 | Scholl Hendrik Peter · Chief Medical Officer | Stock Option (right to buy) | J — Other acquisition or disposition | +10,000 | SEC filing |
| 2026-04-21 | Chuang Hao-Yuan · Chief Financial Officer | Ordinary Share | J — Other acquisition or disposition | +10,000 | SEC filing |
Showing 3 of 3 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.